510(k) Report

510(k) · Cleared

Cleared

Abbott Phenobarbital Assay

K123271510(k) TraditionalCleared Apr 26, 2013189-day reviewClass II21 CFR 862.3660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Microgenics Corp. · DLZ Enzyme Immunoassay, Phenobarbital

Cleared on Apr 26, 2013 as substantially equivalent to K993031 (Syva Co., 2000) after a 189-day review. Its family tree reaches back 2 generations to 1991.

Decided
Apr 26, 2013
Review
189 days
Class
Class II
Product code
DLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K913190 (1991). No later device cites it as a predicate yet.

  1. Root · 2 generations backK913190 Emit (R) 2000 Phenobarbital Assay/CalibratorsSyva Co. · 1991 · Recalled
  2. 1 generation backK993031 Abbott Aeroset Phenobarbital Assey and Calibrators;Models 1E08 and…Syva Co. · 2000 · Recalled
  3. This deviceK123271 Abbott Phenobarbital AssayMicrogenics Corp. · 2013
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K913190Emit (R) 2000 Phenobarbital Assay/CalibratorsSyva Co.19913
−1K993031Abbott Aeroset Phenobarbital Assey and Calibrators;Models 1E08 and 5F54Syva Co.20002
0 (this device)K123271Abbott Phenobarbital AssayMicrogenics Corp.2013—
FIG. 1 — Lineage of K123271, 1991–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DLZ device

  1. #1 K210858 VITROS Chemistry Products PHBR Slidesscore 2.1 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K993031Abbott Aeroset Phenobarbital Assey and Calibrators;Models 1E08 and 5F54
Summary page 3
…cate Proprietary Abbott Phenobarbital Assay Abbott Aeroset" Phenobarbital Assay Name (k993031) Intended Use The Phenobarbital assay is used for the in The assay is intended for use in the vitro quan…
Syva Co.20002

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 2 companies; a new generation was cleared every 13.2 years on median.
  • 2 of the 2 ancestors have a recall of any class.

How does its category compare?

All DLZ devices

DLZ Enzyme Immunoassay, Phenobarbital: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · DLZ

1in 2021

2007: 12008: 12013: 12021: 1
2007high 1 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DLZ

Too few DLZ 510(k)s in any year since 2007 to give a median.

Recalls per year · DLZ

2in 2013

2009: 12011: 12012: 22013: 2
2007high 2 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DLZ

1in 2024

2007: 32011: 582012: 2222013: 1012023: 72024: 1
2007high 222 (2012) · low 0 (2008)2025

MAUDE reports naming product code DLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—03
20081—00
20090—10
20100—00
20110—158
20120—2222
20131—2101
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20211—00
20220—00
20230—07
20240—01
20250—00
20260—0—

What is it indicated for?

The Abbott Phenobarbital assay is for in vitro diagnostic use for the quantitative measurement of phenobarbital in human serum or plasma on the ARCHITECT cSystems. The measurements obtained are used in the diagnosis and treatment of phenobarbital overdose and in monitoring levels of phenobarbital to help ensure appropriate therapy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K123271: Abbott Phenobarbital Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K123271

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026